ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 147 filers reported holding ITEOS THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.33 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $165 | -17.1% | 15,100 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $199 | -85.9% | 15,100 | -85.5% | 0.00% | -50.0% |
| Q1 2023 | $1,416 | +150.2% | 104,100 | +259.0% | 0.00% | -33.3% |
| Q4 2022 | $566 | -99.9% | 29,000 | -9.9% | 0.00% | 0.0% |
| Q3 2022 | $613,000 | -3.6% | 32,200 | +4.2% | 0.00% | 0.0% |
| Q2 2022 | $636,000 | -9.7% | 30,900 | +41.1% | 0.00% | 0.0% |
| Q1 2022 | $704,000 | -33.3% | 21,900 | -3.5% | 0.00% | -25.0% |
| Q4 2021 | $1,056,000 | +259.2% | 22,700 | +108.3% | 0.00% | +300.0% |
| Q3 2021 | $294,000 | -39.8% | 10,900 | -23.8% | 0.00% | -50.0% |
| Q1 2021 | $488,000 | +436.3% | 14,300 | +429.6% | 0.00% | – |
| Q4 2020 | $91,000 | +37.9% | 2,700 | 0.0% | 0.00% | – |
| Q3 2020 | $66,000 | – | 2,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,738,785 | $37,274,864 | 15.53% |
| MPM BioImpact LLC | 1,745,943 | $23,762,284 | 6.17% |
| Saturn V Capital Management LP | 480,653 | $6,541,687 | 4.89% |
| Boxer Capital, LLC | 2,154,058 | $29,317 | 1.44% |
| RA Capital Management | 4,417,259 | $60,118,895 | 1.36% |
| Octagon Capital Advisors LP | 596,000 | $8,111,560 | 1.17% |
| BVF INC/IL | 1,810,835 | $24,645,464 | 0.90% |
| AlphaCentric Advisors LLC | 63,000 | $857,430 | 0.59% |
| Integral Health Asset Management, LLC | 180,000 | $2,449,800 | 0.49% |
| 683 Capital Management, LLC | 480,000 | $6,532,800 | 0.49% |